Skip to content
National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Division of Cancer Prevention logo
Home Site Map Contact DCP
Programs & Resources

Breast and Gynecologic Cancer Research Group

Publications

View All  |  2012-2010  |  2009-2004

  • Under development
  • Under development
  • Agurs-Collins T, Dunn BK, Browne D, Johnson KA, Lubet R. Epidemiology of health disparities in relation to the biology of estrogen receptor-negative breast cancer. Semin Oncol. 2010 Aug;37(4):384-401.
    [ PubMed Abstract ]
  • Eng-Wong J, Venzon D, Cohen P, Isaacs C, Warren R, Wedam S, Zujewski JA, Korde L. Effect of exemestane on mammographic density in postmenopausal women at risk for breast cancer. San Antonio Breast Cancer Symposium 2010 Abstract P1-07-03.
  • Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Petroff BK, Khan QJ, Sharma P, Setchell KD, Zhao X, Phillips TA, Metheny T, Hughes JR, Yeh HW, Johnson KA. Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside. Cancer Prev Res. 2010 Oct;3(10):1342-1350.
    [ PubMed Abstract ]
  • Huang L, Johnson KA, Mariotto AB, Dignam JJ, Feuer EJ. Population-based survival-cure analysis of ER-negative breast cancer. Breast Cancer Res Treat. 2010 Aug;123(1):257-264.
    [ PubMed Abstract ]
  • Johnson KA, Brown PH. Drug development for cancer chemoprevention: focus on molecular targets. Seminars in Oncology, 2010. 37(4):345-358.
    [ PubMed Abstract ]
  • McHenry PR, Sears JC, Herrick MP, Chang P, Heckman-Stoddard BM, Rybarczyk M, Chodosh LA, Gunther EJ, Hilsenbeck SG, Rosen JM, Vargo-Gogola T. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis. Breast Cancer Res. 2010 Sep 22;12(5):R73.
    [ PubMed Abstract ]
  • Porras C, Bennett C, Safaeian M, Coseo S, Rodríguez AC, González P, Hutchinson M, Jiménez S, Sherman ME, Wacholder S, Solomon D, van Doorn LJ, Bougelet C, Quint W, Schiffman M, Herrero R, Hildesheim A; Costa Rica HPV Vaccine Trial (CVT) Group. Determinants of seropositivity among HPV-16/18 DNA positive young women. BMC Infect Dis. 2010 Aug 11;10:238.
    [ PubMed Abstract ]
  • Zou C, Liu H, Feugang JM, Hao Z, Chow HH, Garcia F. Green tea compound in chemoprevention of cervical cancer. Int J Gynecol Cancer. 2010 May;20(4):617-24.
    [ PubMed Abstract ]